AXXAM

info@axxam.com

Event

Lunch & Learn with FCDI | Axxam

Lunch & Learn

📅 Date: October 24, 2025 
📍 Location: Cambridge, MA, USA

Request a meeting

Tom Grammatopoulos,

BD Senior Director  North America

Anna Mondini, Head, Electrophysiology

Register for the event

Synergistic Platforms for Next-Generation Drug Discovery: Integrating iPSC Assay Development and High-Throughput Screening

Axxam and FUJIFILM Cellular Dynamics, Inc. (FCDI) are pleased to co-host a Science and Networking seminar dedicated to the integration of high-throughput functional screening with clinically relevant, patient-derived iPSC models to accelerate early-stage drug discovery.


The event will take place on Friday, October 24, 2025, at FUJIFILM’s Cambridge facility in Massachusetts, and will bring together experts from both organizations to discuss how these technologies are transforming discovery programs and advancing promising results toward clinical application.

Through scientific presentations, case studies, and open networking, participants will gain new perspectives on how combining iPSC-based disease models and advanced screening platforms creates actionable insights for cardiovascular, neurodegenerative, and other therapeutic areas.

What you’ll learn

The seminar will explore how integrated platforms — from iPSC assay development to automated high-throughput screening — are helping scientists design more predictive discovery workflows.
Attendees will discover practical approaches to model disease complexity in vitro and translate findings into robust, clinically relevant data.
Topics will include the development of multi-cellular human systems, adaptation to automation, and application examples that bridge innovative biology and chemistry.

Axxam presentation highlights

Representing Axxam, Tom Grammatopoulos, PhD, Senior Director of Business Development, and Anna Mondini, PhD, Head of the Electrophysiology Group, will introduce how Axxam’s integrated discovery capabilities and iPSC-based assays are shaping the next generation of screening campaigns.

Their contributions will focus on:

  • Integrating drug discovery programs from biology to chemistry

  • Miniaturization and adaptation to automation to increase throughput

  • Development of iPSC-based assays using neurons and cardiomyocytes

  • Establishment of relevant disease models (e.g. Parkinson’s, Alzheimer’s, ALS)

  • Application of Axxam’s proprietary Lysopatch technology to study TMEM175

🔹 Talks

  • “Drug Discovery: Bridging Innovative Biology and Bioactive Molecules through iPSC Models and Beyond”
    Tom Grammatopoulos, PhD – Axxam

  • “Decoding TMEM175 Function: Integrating High-Throughput Data with Neuronal Models”
    Anna Mondini, PhD – Axxam

FCDI presentation highlights

FCDI will showcase their expertise in human iPSC technology, emphasizing:

  • Developing robust in vitro human disease models for drug discovery

  • Leveraging complex culture formats to enhance physiological relevance

  • Case studies applying cardiac safety and neurodegenerative models

Speaker:
Eugenia Jones, PhD – VP, External Developments & Partnerships, FUJIFILM Cellular Dynamics

Her talk, “iPSC-based Models for Drug Discovery: Multi-cellular Systems Integrating Immune Compartments Across Cardiac, Hepatic, and Neural Therapeutic Areas,” will open the session.

Why attend

This seminar is designed for scientists, business developers, and R&D professionals interested in next-generation cell-based discovery.
Participants will gain first-hand insight into how iPSC models are transforming disease-relevant assay design, supporting mechanistic understanding, and bridging the gap between early discovery and clinical translation.
Beyond the talks, the event offers a relaxed networking environment where attendees can connect with peers, share experiences, and discuss potential collaborations with both the Axxam and FCDI teams.

Registration

Participation is free but registration is required due to limited seating.
Join us for this opportunity to exchange ideas, explore collaborative opportunities, and enjoy a light lunch with colleagues in Cambridge.

Register for the event
Back
Scroll to Top